Resources
musculoskeletal
Tendon & ligament injury
Soft-tissue recovery is the most commonly reported off-label use of regenerative peptides. Human evidence remains limited.
Outcomes this condition tracks
Why certain peptides surface — weighted by clinical relevance.
Tissue & joint repair
weight 1.00Most commonly reported off-label use of regenerative peptides.
Recovery time
weight 0.70Tendon/ligament recovery window shortening, anecdotal.
Evidence matrix
Outcome × ingredient signal — backed by indexed studies.
Each cell shows the clinical signal status and the count of indexed studies for that ingredient × outcome pair. Click any cell to open the ingredient brief.
| Outcome \ Ingredient | BPC-157 | KPV | Tesamorelin | Ipamorelin | CJC-1295 (with DAC) | CJC-1295 (no DAC) | Sermorelin | MK-677 | TB-500 | GHK-Cu |
|---|---|---|---|---|---|---|---|---|---|---|
| Tissue & joint repair | ·— | ·— | — | — | — | — | — | — | ·— | ·— |
| Recovery time | ·— | ·— | ·— | ·— | ·— | ·— | ·— | ·— | ·— | — |
04Canonical, evidence-anchored
Matched protocol templates for this condition.
Matching templates…
Reported substances
What cohorts have used — and at what tier of evidence.
Suggestive, never prescriptive. Mydosage does not recommend a dose, a substance or a protocol. Decisions belong with you and a clinician.